GlassScriptPhysician profile
Frank Schlehr
NPI 1982605499
$7,089.88
in general payments reported to CMS, 2019-2025
17 companies · $22.56 in 2025
The $22.56 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,454 · 2020: $833 · 2021: $260 · 2022: $152 · 2023: $157 · 2024: $212 · 2025: $22.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,641.67 | 2019-2020 | |
| Prodigy Surgical Distribution, INC. | $1,094.00 | 2019 | |
| Pacira Therapeutics, INC. | $468.71 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $198.92 | 2019-2025 | Euflexxa |
| Horizon Therapeutics Plc | $116.70 | 2019-2023 | Krystexxa |
| Bioventus LLC | $97.06 | 2019-2023 | Gelsyn-3 |
| Amgen INC. | $75.75 | 2021-2024 | Krystexxa |
| Depuy Synthes Sales INC. | $67.12 | 2024 | Orthovisc, Monovisc |
| Smith+Nephew, INC. | $59.59 | 2023 | Firstpass, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Pacira Pharmaceuticals Incorporated | $59.14 | 2022-2023 | Zilretta, Exparel |
| Kowa Pharmaceuticals America, INC. | $49.38 | 2022-2023 | Seglentis |
| Fidia Pharma USA INC. | $47.28 | 2022-2024 | Triluron, Hymovis, Hyalgan |
| Stryker Corporation | $36.23 | 2019 | |
| Avanos Medical | $26.90 | 2024 | Trivisc Sodium Hyaluronate |
| Zimmer Biomet Holdings, INC. | $21.08 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.36 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Schlehr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.